参与焦点粘附信号的机制 调节瘤 Anoikis 抵抗
Bin Liu1,2, Qingqing Wu1,2, Zuodong Xuan1,2
1School of Medicine, Xiamen University, Xiamen, China.
Cancer science
|August 5, 2025
概括
瘤细胞通过改变焦点粘附信号来抵抗细胞死亡过程 - - anoikis. 本综述探讨了整合素表达,氧化应激和信号通路的变化如何使癌细胞转移.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 瘤转移是癌症死亡的主要原因.
- 阿诺基斯是一种由细胞脱离引发的亡形式,通常可以防止转移.
- 对阿诺基斯的耐药性是癌细胞扩散的关键一步.
研究的目的:
- 审查瘤细胞中阿诺基斯抗性的机制.
- 阐明焦点粘附信号通路在抗氧化物抵抗中的作用.
- 为了描述抗阿诺基斯状态的分子特征.
主要方法:
- 关于焦点粘附复合体和信号的文献综述.
- 分析导致阿诺基斯耐药性的因素,包括整蛋白表达和氧化应激.
- 讨论由焦点粘附激活的下游生存信号通路.
主要成果:
- 焦点粘附是多蛋白信号复合体,对细胞生存至关重要.
- 整合素表达的变化,细胞内氧化应激增加和下游生存途径的激活有助于阿诺基的抗性.
- 特定的分子变化定义了抗阿诺基斯的表型.
结论:
- 焦点粘附信号通路是癌细胞中抗氧化物抵抗的关键调节者.
- 了解这些机制对于开发抑制癌症转移的策略至关重要.
更多相关视频
10:57Examining the Dynamics of Cellular Adhesion and Spreading of Epithelial Cells on Fibronectin During Oxidative Stress
Published on: October 13, 2019
7.6K
08:51A Real-time Electrical Impedance Based Technique to Measure Invasion of Endothelial Cell Monolayer by Cancer Cells
Published on: April 1, 2011
27.4K
相关概念视频
Intracellular Signaling Affects Focal Adhesions
2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.8K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
